109 related articles for article (PubMed ID: 21669151)
1. Local adjuvants in surgical management of bone metastases.
Piccioli A; Ventura A; Maccauro G; Spinelli MS; Del Bravo V; Rosa MA
Int J Immunopathol Pharmacol; 2011; 24(1 Suppl 2):129-32. PubMed ID: 21669151
[TBL] [Abstract][Full Text] [Related]
2. Local Adjuvant Substances Following Curettage of Bone Tumors.
Bickels J; Campanacci DA
J Bone Joint Surg Am; 2020 Jan; 102(2):164-174. PubMed ID: 31613863
[No Abstract] [Full Text] [Related]
3. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy.
; Becker WT; Dohle J; Bernd L; Braun A; Cserhati M; Enderle A; Hovy L; Matejovsky Z; Szendroi M; Trieb K; Tunn PU
J Bone Joint Surg Am; 2008 May; 90(5):1060-7. PubMed ID: 18451399
[TBL] [Abstract][Full Text] [Related]
4. Phenol as an adjuvant for local control in the treatment of giant cell tumour of the bone.
Dürr HR; Maier M; Jansson V; Baur A; Refior HJ
Eur J Surg Oncol; 1999 Dec; 25(6):610-8. PubMed ID: 10556009
[TBL] [Abstract][Full Text] [Related]
5. Giant cell tumour of bone in the appendicular skeleton: an analysis of 276 cases.
Xing R; Yang J; Kong Q; Tu C; Zhou Y; Duan H
Acta Orthop Belg; 2013 Dec; 79(6):731-7. PubMed ID: 24563982
[TBL] [Abstract][Full Text] [Related]
6. Giant cell tumor of bone: risk factors for recurrence.
Klenke FM; Wenger DE; Inwards CY; Rose PS; Sim FH
Clin Orthop Relat Res; 2011 Feb; 469(2):591-9. PubMed ID: 20706812
[TBL] [Abstract][Full Text] [Related]
7. Subchondral giant-cell tumor of the proximal tibia: arthroscopic treatment for accelerated articular cartilage and meniscal degeneration in two patients.
Tejwani SG; Hame SL; Eckardt JJ
Arthroscopy; 2004 Jul; 20(6):644-9. PubMed ID: 15241319
[TBL] [Abstract][Full Text] [Related]
8. Intralesional curettage, with phenol and cement as adjuvants, for low-grade intramedullary chondrosarcoma of the long bones.
Di Giorgio L; Touloupakis G; Vitullo F; Sodano L; Mastantuono M; Villani C
Acta Orthop Belg; 2011 Oct; 77(5):666-9. PubMed ID: 22187844
[TBL] [Abstract][Full Text] [Related]
9. Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy.
Trieb K; Bitzan P; Lang S; Dominkus M; Kotz R
Eur J Surg Oncol; 2001 Mar; 27(2):200-2. PubMed ID: 11289759
[TBL] [Abstract][Full Text] [Related]
10. Aggressive treatment of giant cell tumour with multiple local adjuvants.
Ofluoglu O
Acta Orthop Belg; 2008 Dec; 74(6):831-6. PubMed ID: 19205332
[TBL] [Abstract][Full Text] [Related]
11. Current status of bone cementing and bone grafting for giant cell tumour of bone: a systemic review.
Vaishya R; Pokhrel A; Agarwal AK; Vijay V
Ann R Coll Surg Engl; 2019 Feb; 101(2):79-85. PubMed ID: 30688529
[TBL] [Abstract][Full Text] [Related]
12. Liquid nitrogen or phenolization for giant cell tumor of bone?: a comparative cohort study of various standard treatments at two tertiary referral centers.
van der Heijden L; van der Geest IC; Schreuder HW; van de Sande MA; Dijkstra PD
J Bone Joint Surg Am; 2014 Mar; 96(5):e35. PubMed ID: 24599207
[TBL] [Abstract][Full Text] [Related]
13. Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone?
Gaston CL; Bhumbra R; Watanuki M; Abudu AT; Carter SR; Jeys LM; Tillman RM; Grimer RJ
J Bone Joint Surg Br; 2011 Dec; 93(12):1665-9. PubMed ID: 22161931
[TBL] [Abstract][Full Text] [Related]
14. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).
Gouin F; Dumaine V;
Orthop Traumatol Surg Res; 2013 Oct; 99(6 Suppl):S313-8. PubMed ID: 23978709
[TBL] [Abstract][Full Text] [Related]
15. Treating giant cell tumours with curettage, electrocautery, burring, phenol irrigation, and cementation.
Moon MS; Kim SS; Moon JL; Kim SS; Moon H
J Orthop Surg (Hong Kong); 2013 Aug; 21(2):209-12. PubMed ID: 24014786
[TBL] [Abstract][Full Text] [Related]
16. Giant cell tumor of the hand: superior results with curettage, cryosurgery, and cementation.
Wittig JC; Simpson BM; Bickels J; Kellar-Graney KL; Malawer MM
J Hand Surg Am; 2001 May; 26(3):546-55. PubMed ID: 11418922
[TBL] [Abstract][Full Text] [Related]
17. [Clinical observation of surgical management for recurrent giant cell tumor of bone].
Kong Q; Yang J; Xing R; Tu C; Zhou Y; Zhang H; Duan H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jan; 27(1):36-40. PubMed ID: 23427489
[TBL] [Abstract][Full Text] [Related]
18. [Process and outcome quality in giant cell tumor in relation to surgical management].
Pingsmann A; Müller RT
Unfallchirurg; 1997 Jul; 100(7):547-51. PubMed ID: 9340780
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment and prognostic factors in giant-cell tumor of bone.
Szendröi M; Kiss J; Antal I
Acta Chir Orthop Traumatol Cech; 2003; 70(3):142-50. PubMed ID: 12882097
[TBL] [Abstract][Full Text] [Related]
20. Local Treatment with Adjuvant Therapy for Central Atypical Cartilaginous Tumors in the Long Bones: Analysis of Outcome and Complications in One Hundred and Eight Patients with a Minimum Follow-up of Two Years.
Dierselhuis EF; Gerbers JG; Ploegmakers JJ; Stevens M; Suurmeijer AJ; Jutte PC
J Bone Joint Surg Am; 2016 Feb; 98(4):303-13. PubMed ID: 26888678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
